| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2025 | Dec 11, 2025 | Aprea Therapeutics, Inc. | CFO | Buy | 90.0 | +5,000 | 21.99% | ✗ | $5.8K |
| Oct 11, 2024 | Oct 16, 2024 | Aprea Therapeutics, Inc. | CFO | Buy | 60.0 | +50 | 0.26% | ✗ | $123.2 |
| Oct 10, 2024 | Oct 15, 2024 | Aprea Therapeutics, Inc. | CFO | Buy | 77.5 | +450 | 2.38% | ✗ | $1.2K |
| Mar 13, 2024 | Mar 14, 2024 | Aprea Therapeutics, Inc. | CFO | Buy | 85.0 | +1,010 | 6.97% | ✗ | $7.4K |
| Jul 26, 2022 | Jul 26, 2022 | WINDTREE THERAPEUTICS INC /DE/ | CFO | Buy | 82.5 | +3,000 | 4.30% | ✗ | $1.1K |
| Apr 16, 2021 | Apr 19, 2021 | WINDTREE THERAPEUTICS INC /DE/ | CFO | Buy | 90.0 | +1,000 | 40.00% | ✗ | $2.1K |
| Mar 25, 2021 | Mar 25, 2021 | WINDTREE THERAPEUTICS INC /DE/ | CFO | Buy | 90.0 | +1,500 | 150.00% | ✗ | $4.9K |
| Oct 7, 2020 | Oct 9, 2020 | WINDTREE THERAPEUTICS INC /DE/ | CFO | Buy | 90.0 | +1,000 | 100.00% | ✗ | $5.3K |